[Exudative otitis media. Modern concepts and the importance of the problem].

The objective of the present work was to analyse current concepts of etiology, pathogenesis, and classification of exudative otitis medium (EOM) in conjunction with the methods for the treatment of this pathology. Views of the problem expressed by different authors (both Russian-speaking and foreign) are discussed. Complications of the disease developing as a result of the untimely or inadequate treatment are described.

[The importance of psychic personality traits and emotional state for diagnostics and treatment of the patient].

It is very important for a physician to be aware not only of objective changes in the somatic status of the patient but also of his or her subjective emotional experience in connection with a given pathology. In everyday life and work, we frequently encounter people differing in psychic traits and emotional status. In the present paper, we describe certain personality types, their characteristic features and types of behaviour in response to the developing pathology.

[Epidemiological characteristic of the patients presenting with cochleovestibular disorders associated with labyrinthine hydrops].

A total of 1,067 patients complaining of hearing impairment, dizziness, and tympanophony were admitted for the treatment to the Surdological Department of N.I. Pirogov City Clinical Hospital No 1 during the period from 2000 to 2010.

[The application of supravascular laser irradiation of blood for the treatment of cochleovestibular disorders].

A total of 165 patients presenting with neurosensory impairement of hearing and Meniere's disease were treated by supravascular (extracorporeal) laser irradiation of blood. The study undertaken to evaluate the efficacy of this treatment confirmed its beneficial effect in patients with acute hearing disorders. It was equally effective as regards elimination of labyrinthine hydropsis in patients presenting with Meniere's disease.

[Assessment of efficacy and tolerance of tanakan during treatment of sensorineural bradyacuasia and tympanophonia].

The objective of the study was to evaluate efficacy and tolerance of tanakan during treatment of neurosensory hearing loss and subjective tinnitis supposedly of vascular etiology. The secondary purpose was to analyse late results of 3 month courses of therapy and changes in the clinical course of the disease during treatment and within 6 months after its termination. Tanakan was first given at a dose of 40 mg thrice daily for 90 days.